![Vertex Pharmaceuticals Inc](/common/images/company/N_VRTX.png)
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In add... Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. Show more
Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for People With Cystic Fibrosis Aged 2 Years and Older With Certain Rare...
- Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorization Application (MAA) submission also validated...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2024 financial results on Thursday, August 1, 2024 after the financial markets close. The company will host a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.27 | 0.870132251951 | 490.73 | 503.99 | 486.25 | 1087303 | 492.14105386 | CS |
4 | 27.06 | 5.78279266573 | 467.94 | 503.99 | 466.01 | 984367 | 486.62342119 | CS |
12 | 93.5 | 23.2876712329 | 401.5 | 503.99 | 394.0323 | 1151518 | 463.17585143 | CS |
26 | 63.97 | 14.8411943484 | 431.03 | 503.99 | 391.01 | 1171794 | 436.85146952 | CS |
52 | 138.74 | 38.9434682535 | 356.26 | 503.99 | 340.2 | 1192860 | 404.64511121 | CS |
156 | 295.28 | 147.84698578 | 199.72 | 503.99 | 176.36 | 1421971 | 302.99937035 | CS |
260 | 324.82 | 190.868492185 | 170.18 | 503.99 | 165.23 | 1549012 | 268.39859431 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.